Enhancing pharmacologic effects in the treatment of depression in women

Journal of Clinical Psychiatry

Volumn 61, Issue SUPPL. 11, 2000, Pages 18-27

  Kornstein, S G ^a   McEnany, G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

COMORBIDITY; DEPRESSION; DRUG METABOLISM; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PUBERTY; REPRODUCTION; REVIEW; SEXUAL DYSFUNCTION; SLEEP DISORDER; SOCIAL ASPECT; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PREVALENCE; SEX FACTORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SLEEP DISORDERS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0033864275     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Sex and depression in the National Comorbidity Survey, I: Lifetime prevalence, chronicity, and recurrence
2. Sex differences in rates of depression: Cross-national perspectives
3. Gender differences in seasonal affective disorder
4. Late luteal phase dysphoric disorder in young women
5. Women with bipolar illness: Clinical and research issues
6. Sex differences in unipolar depression: Evidence and theory
7. Women and depression
8. Women's vulnerability to mood disorders: Integrating psychobiology and epidemiology
9. Gender differences in depression: Implications for treatment
10. Sex differences in recurrent depression: Are there any that are significant?
11. Gender differences in the clinical features of unipolar depressive disorder
12. Gender differences in presentation of chronic major depression
13. Gender differences in chronic major and double depression
14. A rating scale for depression
15. New depression scale designed to be sensitive to change
16. An inventory for measuring depression
17. Do the diagnostic criteria determine the sex ratio in depression?
18. Suicide in major depression
19. Factors associated with one-year outcome of major depression in the community
20. The natural history of depressive symptoms
21. The Zurich study, XII: Sex differences in depression: Evidence from longitudinal epidemiological data
22. A prospective follow-up of patients with bipolar and primary unipolar affective disorder
23. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey
24. Comorbidity of affective and anxiety disorders in the NIMH Epidemiologic Catchment Area Program
25. Gender differences in Axis I comorbidity among depressed outpatients
26. Anxiety symptom relief in depression treatment outcomes
27. Predictors of early suicide: Identification and appropriate intervention
28. Gender differences in DSM-IV alcohol use disorders and major depression as distributed in the general population: Clinical implications
29. Gender differences in the relation between depressive symptoms and alcohol problems: A longitudinal perspective
30. Association between major depressive disorder and physical illness
31. Comorbidity of migraine and major affective disorders
32. Fibromyalgia: More than just a musculoskeletal disease
33. Sex differences in thyroid axis dysfunction: Relevance to affective disorder and its treatment
34. The Camberwell Collaborative Depression Study, I: Depressed probands: Adversity and the form of depression
35. Gender and marital status differences in depression: The effects of chronic strains
36. Men at work and out of work
37. Child care and emotional adjustment to wives' employment
38. Victims of violence and psychiatric illness
39. The menstrual cycle and mood disorders
40. Premenstrual exacerbation of depression
41. Controlled prospective study of postpartum mood disorders: Psychological, environmental, and hormonal factors
42. Psychotropic drug use during pregnancy: Weighing the risks
43. Course of mood and anxiety disorders during pregnancy and postpartum period
44. Self-reported depression and negative pregnancy outcomes
45. The assessment and treatment of postpartum psychiatric disorders
46. Postpartum mood disorders: Diagnosis and treatment guidelines
47. Psychotropic medications in lactation
48. Psychopharmacological treatment during pregnancy and lactation
49. Depressive symptoms in the perimenopause: Prevalence, assessment, and guidelines for treatment
50. Psychosocial stress and symptoms of menopause: A comparative study of menopause clinic patients and non-patients
51. Psychological distress during menopause: Associations across the reproductive cycle
52. A longitudinal analysis of the association between menopause and depression: Results from the Massachusetts Women's Health Study
53. A meta-analysis of the effect of hormone replacement therapy upon depressed mood
54. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial
55. Estrogen replacement therapy status and antidepressant to sertraline
56. Gender effects in the treatment of depression
57. Sex differences in pharmacokinetics of psychotropic medications, part I: Physiological basis for effects
58. Sex-related differences in response to treatments of depression
59. Sex and treatment of depressions: When does it matter?
60. Forms of atypical depression and their response to antidepressant drugs
61. Gender differences in treatment response to sertraline and imipramine in chronic depression
62. Age-sex differences in response to antidepressant drugs
63. The treatment of chronic depression, part 2: A double-blind randomized trial of sertraline and imipramine
64. The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine
65. Enhancement of imipramine antidepressant activity by thyroid hormone
66. REM latency and core temperature relationships in primary depression
67. Effects of phototherapy on nonseasonal, nonbipolar major depression in women: A randomized, placebo controlled trial
68. Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention?
69. Relationship between objective and subjective sleep measures in depressed patients and healthy controls
70. Sex differences in the distribution of EEG frequencies during sleep: Unipolar depressed outpatients
71. Fluoxetine and oculomotor activity during sleep in depressed patients
72. Sleep research in affective illness: State of the art circa 1987
73. Sex, steroids and sleep: A review
74. Circadian temperature rhythm in relation to menstrual cycle phase
75. Core body temperature during menopausal hot flushes
76. Core body temperature and circadian rhythm of hot flashes in perimenopausal women
77. Sleep disruption and mood changes associated with menopause
78. Sleep patterns and stability in perimenopausal women
79. The thermoregulatory effects of menopausal hot flashes on sleep
80. Sleep reduction as the final common pathway in the genesis of mania
81. Treatment issues related to sleep and depression
82. Effects of antidepressant treatment on sleep EEG in depression
83. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
84. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients
85. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: A double-blind, 8-week clinical trial
86. Somatic symptoms in primary affective disorder: Presence and relationship of the classification of depression
87. The role of antidepressants in sexual dysfunction
88. Sexual side effects of antidepressants
89. Antidepressant-induced sexual dysfunction
90. Female sexual side effects associated with selective serotonin reuptake inhibitors: A descriptive clinical study of 33 patients
91. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
92. Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction
93. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients
94. Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects
95. Weight gain associated with use of psychotropic medications
96. Prescription medications: A modifiable contributor to obesity
97. Weight gain in depression remitted with antidepressants: Pharmacological or recovery effect?
98. Weight gain and antidepressants
99. Weight gain associated with SSRIs
100. Mirtazapine versus amitriptyline in the long-term treatment of depression: A double-blind placebo-controlled study